Supplementary Figure S4 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Qun Chen
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
66Publications signalées
49Citations signalées
0Affiliations récentes
Domaines associés
Glioma Diagnosis and TreatmentLung Cancer Research StudiesNeuroblastoma Research and TreatmentsManagement of metastatic bone diseaseBrain Metastases and Treatment
Publications récentes
Supplementary Figure S5 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Table S1 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Table S2 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Figure S6 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Figure S1 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Figure S2 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Table S3 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Figure S3 from RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Renya Zhan, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Figure S6 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Kaiyuan Huang, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Figure S2 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Kaiyuan Huang, Xiangqi Meng, Yuxiang Weng et autres
0 citations
Supplementary Figure S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Qingsheng Xu, Kaiyuan Huang, Xiangqi Meng, Yuxiang Weng et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.